About the journal
Recent Patents on Anti-Cancer Drug Discovery is a journal published by Bentham Science Publishers in Netherlands. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Bentham Science Publishers
- ISSN
- 1574-8928 · 2212-3970
- Country
- Netherlands
- Access
- Not open access / not declared
Index listings
- MEDLINE · 2006-01-01
- PUBMED · 2012-05-01
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 82 days received→accepted — computed from PubMed (n=100)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
854
Last recorded publication year
2026
h-index
59
i10-index
357
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- Portico
- Open references deposited at Crossref
- 66%
- ORCID iDs in current deposits
- 29%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101266081
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Diverse Scientific and Economic Studies
- Diverse Scientific and Economic Studies
- Legal Cases and Commentary
- Legal Cases and Commentary
- Intellectual Property and Patents
- Intellectual Property and Patents
- Cancer Mechanisms and Therapy
- Cancer Mechanisms and Therapy
Show all subjects (50)
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Cancer Research and Treatment
- Cancer Research and Treatment
- Cancer Research and Treatments
- Cancer Research and Treatments
- 14-3-3 protein interactions
- Nanoparticle-Based Drug Delivery
- Nanoparticle-Based Drug Delivery
- 14-3-3 protein interactions
- Cell death mechanisms and regulation
- Cell death mechanisms and regulation
- Cancer, Lipids, and Metabolism
- Cancer, Lipids, and Metabolism
- Human auditory perception and evaluation
- Human auditory perception and evaluation
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- Synthesis and biological activity
- Synthesis and biological activity
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Histone Deacetylase Inhibitors Research
- HER2/EGFR in Cancer Research
- Histone Deacetylase Inhibitors Research
- Cancer, Stress, Anesthesia, and Immune Response
- Cancer, Stress, Anesthesia, and Immune Response
- Computational Drug Discovery Methods
- HER2/EGFR in Cancer Research
- Advanced Breast Cancer Therapies
- Computational Drug Discovery Methods
- Biological Research and Disease Studies
- Advanced Breast Cancer Therapies
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Biological Research and Disease Studies
- Microtubule and mitosis dynamics
- Microtubule and mitosis dynamics
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ